Cargando…
Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849 + 10 kb C-to-T splicing mutation
BACKGROUND: Antisense oligonucleotide (ASO)-based drugs for splicing modulation were recently approved for various genetic diseases with unmet need. Here we aimed to develop an ASO-based splicing modulation therapy for Cystic Fibrosis (CF) patients carrying the 3849 + 10 kb C-to-T splicing mutation...
Autores principales: | Oren, Yifat S., Irony-Tur Sinai, Michal, Golec, Anita, Barchad-Avitzur, Ofra, Mutyam, Venkateshwar, Li, Yao, Hong, Jeong, Ozeri-Galai, Efrat, Hatton, Aurélie, Leibson, Chen, Carmel, Liran, Reiter, Joel, Sorscher, Eric J., Wilton, Steve D., Kerem, Eitan, Rowe, Steven M., Sermet-Gaudelus, Isabelle, Kerem, Batsheva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464507/ https://www.ncbi.nlm.nih.gov/pubmed/34226157 http://dx.doi.org/10.1016/j.jcf.2021.06.003 |
Ejemplares similares
-
Topoisomerase 1-dependent R-loop deficiency drives accelerated replication and genomic instability
por: Sarni, Dan, et al.
Publicado: (2022) -
Ivacaftor in People with Cystic Fibrosis and a 3849+10kb C→T or D1152H Residual Function Mutation
por: Kerem, Eitan, et al.
Publicado: (2021) -
AT-dinucleotide rich sequences drive fragile site formation
por: Irony-Tur Sinai, Michal, et al.
Publicado: (2019) -
The presence of extra chromosomes leads to genomic instability
por: Passerini, Verena, et al.
Publicado: (2016) -
A Case of Cystic Fibrosis With a Rare Mutation (3849 + 10 kbC > T) and Normal Sweat Chloride Levels
por: Ozdemir, Taha Resid, et al.
Publicado: (2015)